Recently, Huang et al. reported that phosphorylation of Dishevelled by RIPK4 regulates the Wnt signaling pathway, and elevated RIPK4 expression promotes ovarian cancer in a xenograft tumor model16, thereby suggesting that RIPK4 may act as an oncogene. Here, RIPK4 is linked to ovarian carcinoma.